Penny Stock to Buy #2 – PharmAthene (PIP)
Biodefense company PharmAthene (AMEX: PIP) develops and commercializes medical countermeasures against biological and chemical weapons. Based in Annapolis, Md., its products are used in the defense of Anthrax, nerve gases and other chemical weapons.
In the last calendar year, PIP stock has gained 94%. Potential buyers should also make note of PIP’s last income statement, in which the penny stock posted a quarterly revenue growth of 103%. PIP also has the ability to grow your portfolio quickly, as it jumped more than 30% in a three-day span in October.
Comments are currently unavailable. Please check back soon.